U.S. Claims Data Reveal Need to Standardize First-Episode Psychosis Incidence Estimates

A new study is drawing attention to a hidden problem in mental-health research: scientists may be using the same words to describe first episode psychosis (FEP) while measuring entirely different things. In an analysis published in Schizophrenia, researchers Seiber, Sridhar, Hasenstab and colleagues examine how U.S. insurance claims data are used to estimate the incidence of FEP—the number of new cases appearing in a population over a defined period—and argue that greater standardization is urgently needed.

First episode psychosis refers to the point at which a person experiences psychotic symptoms for the first time in their life. These symptoms can include hallucinations, delusions, disorganized thinking or major changes in behavior and functioning. FEP is not a single diagnosis. It can occur in schizophrenia-spectrum disorders, bipolar disorder, severe depression and several medical or substance-related conditions. Because early treatment is linked to better long-term outcomes, knowing how often FEP occurs is essential for planning specialized clinics, staffing early-intervention programs and directing public-health resources.

The researchers focus on U.S. claims data, enormous digital records generated when patients receive medical care and providers submit bills to insurers. These databases can include diagnostic codes, procedure codes, prescription information, dates of service and details about emergency, inpatient and outpatient treatment. Unlike traditional epidemiological surveys, claims datasets can cover millions of people and make it possible to study patterns across large geographic areas. Their scale, however, does not automatically make their estimates precise.

The central challenge is that a billing code is not the same as a clinical assessment. A code for psychosis may indicate a confirmed diagnosis, a suspected condition, a historical problem or a provisional label assigned during an emergency evaluation. Claims data also rarely contain the complete clinical narrative needed to determine whether symptoms truly represent a person’s first psychotic episode. A patient may have received care in another health system, paid out of pocket, changed insurers or carried an earlier diagnosis that is invisible in the database being studied.

Even the definition of “incidence” can vary. Some researchers count a first-ever psychosis-related diagnosis, while others count a first hospitalization, a first emergency-department visit or the first appearance of a relevant code after a period without documented care. These approaches can produce different numbers from the same underlying population. A study requiring a long “clean period”—a span of time with no previous psychosis-related claims—may reduce the likelihood of counting established cases as new, but it can also exclude people whose earlier treatment occurred outside the available records.

Age, sex, insurance type and geography can further influence the apparent rate of FEP. Young adults may be more likely to encounter emergency services, while people in rural areas may face limited access to psychiatrists and specialized programs. Differences in insurance coverage can determine which services generate observable claims. If researchers compare estimates without accounting for these factors, they may mistake variations in detection or access for genuine differences in disease occurrence.

The study’s call for standardization points toward a more consistent technical framework. Researchers need to specify which diagnostic codes qualify as psychosis, whether substance-induced and medically caused episodes are included, how long a person must remain free of prior claims to be considered a new case, and which healthcare settings are examined. They also need to define the population denominator—the number of people considered at risk—and explain how individuals with incomplete enrollment or interrupted insurance coverage are handled.

Validation is another crucial step. Claims-based algorithms should be compared with detailed chart reviews, clinical registries or structured assessments to determine how accurately they identify genuine FEP. Two statistical measures are especially important: sensitivity, or the ability to capture true cases, and positive predictive value, or the proportion of algorithm-identified cases that are confirmed after review. An algorithm with high sensitivity may find more possible cases but also produce more false positives; one with high specificity may miss people who received vague or inconsistent coding.

Standardized methods could make FEP estimates more comparable across states, insurers and research teams. That would help scientists detect real trends rather than methodological noise and could reveal whether early psychosis services are reaching the populations most in need. More reliable estimates could also strengthen efforts to investigate racial, socioeconomic and regional disparities, provided that claims data are interpreted carefully and not treated as a complete substitute for clinical information.

The message from the research is not that U.S. claims databases are unusable. On the contrary, their breadth makes them one of the most powerful tools available for studying mental-health care at scale. But their value depends on transparent definitions, validated case-finding methods and clear reporting standards. As health systems increasingly rely on administrative data and automated analytics, agreeing on what counts as a new case of psychosis may be the difference between a map that reveals a public-health crisis and one that merely reflects the quirks of the billing system.